Telomir Pharmaceuticals:Telomir-1药物可重置DNA甲基化并恢复肿瘤抑制因子功能——SEC文件披露

美股速递
Oct 07, 2025

根据SEC文件披露,Telomir Pharmaceuticals表示,其研发的Telomir-1药物能够重置DNA甲基化,从而恢复肿瘤抑制因子的功能。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10